Ian Shelton

Ian Shelton is a highly skilled professional with extensive experience in venture and business development, particularly within the healthcare and biotech sectors. Currently serving as a Senior Venture/Business Development Fellow at CU Innovations, Ian has facilitated a joint venture with Argenx and is involved in developing clinical trial strategies. As a Scientific and Business Advisor for RefinedSciences, Ian leads asset selection efforts while leveraging an analytical model for high-quality asset identification. Additionally, Ian is a Senior Venture Fellow for the CU Healthcare Innovation Fund, focusing on sourcing and due diligence for pharma investments. Ian is pursuing a PhD in Cancer Pharmacology at the University of Colorado Anschutz Medical Campus, with a research focus on Acute Myeloid Leukemia. Previous roles include Clinical Research Scientist specializing in neuroimmunology and research experience in multiple sclerosis. Ian holds a Biology and Economics/Finance degree from Claremont McKenna College.